Immunovirological parameters and cytokines in HIV infection

Although modern combined antiretroviral therapies (cART) result in lower morbidity and mortality and a visible improvement of clinical and laboratory parameters in HIV-infected, it is known that their long-term use contributes to appearance of the many events unrelated to AIDS such as cardiovascular diseases, cancer and osteoporosis, comorbidities which have been proposed as some of the most important that deprive the majority of infected to present an even better prognosis. This is because even with a decrease in inflammation and immune activation after drug intervention to the patient, these parameters remain higher than those shown by healthy individuals and the imbalance of cytokine profiles also persists. Therefore, evaluations of other biomarkers in clinical practice are needed to complement the exams already carried out routinely and allow more effective monitoring of HIV patients. This review aims to investigate the role of cytokines as potential markers showing studies on their behavior in various stages of HIV infection, with or without cART.

Saved in:
Bibliographic Details
Main Authors: Tasca,Karen Ingrid, Calvi,Sueli Aparecida, Souza,Lenice do Rosário de
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Medicina Tropical - SBMT 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000600002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0037-86822012000600002
record_format ojs
spelling oai:scielo:S0037-868220120006000022013-01-04Immunovirological parameters and cytokines in HIV infectionTasca,Karen IngridCalvi,Sueli AparecidaSouza,Lenice do Rosário de Cytokines HIV/AIDS Antiretroviral therapy Clinical stages of infection Although modern combined antiretroviral therapies (cART) result in lower morbidity and mortality and a visible improvement of clinical and laboratory parameters in HIV-infected, it is known that their long-term use contributes to appearance of the many events unrelated to AIDS such as cardiovascular diseases, cancer and osteoporosis, comorbidities which have been proposed as some of the most important that deprive the majority of infected to present an even better prognosis. This is because even with a decrease in inflammation and immune activation after drug intervention to the patient, these parameters remain higher than those shown by healthy individuals and the imbalance of cytokine profiles also persists. Therefore, evaluations of other biomarkers in clinical practice are needed to complement the exams already carried out routinely and allow more effective monitoring of HIV patients. This review aims to investigate the role of cytokines as potential markers showing studies on their behavior in various stages of HIV infection, with or without cART.info:eu-repo/semantics/openAccessSociedade Brasileira de Medicina Tropical - SBMTRevista da Sociedade Brasileira de Medicina Tropical v.45 n.6 20122012-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000600002en10.1590/S0037-86822012000600002
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Tasca,Karen Ingrid
Calvi,Sueli Aparecida
Souza,Lenice do Rosário de
spellingShingle Tasca,Karen Ingrid
Calvi,Sueli Aparecida
Souza,Lenice do Rosário de
Immunovirological parameters and cytokines in HIV infection
author_facet Tasca,Karen Ingrid
Calvi,Sueli Aparecida
Souza,Lenice do Rosário de
author_sort Tasca,Karen Ingrid
title Immunovirological parameters and cytokines in HIV infection
title_short Immunovirological parameters and cytokines in HIV infection
title_full Immunovirological parameters and cytokines in HIV infection
title_fullStr Immunovirological parameters and cytokines in HIV infection
title_full_unstemmed Immunovirological parameters and cytokines in HIV infection
title_sort immunovirological parameters and cytokines in hiv infection
description Although modern combined antiretroviral therapies (cART) result in lower morbidity and mortality and a visible improvement of clinical and laboratory parameters in HIV-infected, it is known that their long-term use contributes to appearance of the many events unrelated to AIDS such as cardiovascular diseases, cancer and osteoporosis, comorbidities which have been proposed as some of the most important that deprive the majority of infected to present an even better prognosis. This is because even with a decrease in inflammation and immune activation after drug intervention to the patient, these parameters remain higher than those shown by healthy individuals and the imbalance of cytokine profiles also persists. Therefore, evaluations of other biomarkers in clinical practice are needed to complement the exams already carried out routinely and allow more effective monitoring of HIV patients. This review aims to investigate the role of cytokines as potential markers showing studies on their behavior in various stages of HIV infection, with or without cART.
publisher Sociedade Brasileira de Medicina Tropical - SBMT
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000600002
work_keys_str_mv AT tascakareningrid immunovirologicalparametersandcytokinesinhivinfection
AT calvisueliaparecida immunovirologicalparametersandcytokinesinhivinfection
AT souzalenicedorosariode immunovirologicalparametersandcytokinesinhivinfection
_version_ 1756380488203763712